Apotex Inc. filed an appeal late Wednesday against the injunction preventing the Canadian drug company from selling a generic version of the heart drug Plavix.
The request, made to the U.S. Court of Appeals for the Federal Circuit in Washington, came a day after a federal judge had denied Apotex's request to postpone his order last week to halt the company's sales of generic Plavix.
More
No comments:
Post a Comment